Concr
Concr is an emerging software platform to combat cancer. It combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment. This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine. Concr aims to: • Reduce treatment resistance • Cut the cost of cancer treatment • Enable proactive treatment adaptation • Save lives
Last updated on
About Concr
Founded
2018Employees
11-50Funding / Mkt. Cap
$691KCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
LondonState
LondonCountry
United KingdomConcr
Find your buyer within Concr